COMMODORE CAPITAL LP ELVN Holdings History

Number of Shares
4.67 Mil
Current Holdings Value*
$92.00 Mil
% of Portfolio
6.78%
Total Estimate Gain
$10.52 Mil
% of Total Estimate Gain
11.38%

COMMODORE CAPITAL LP's Enliven Therapeutics Inc Holding Summary

As of 2025-03-31, COMMODORE CAPITAL LP held 4.67 Mil shares of Enliven Therapeutics Inc(ELVN), totaling $92.00 Mil. This investment constitutes 6.78% of their stock portfolio, and COMMODORE CAPITAL LP now holds 9.53% of the outstanding Enliven Therapeutics Inc(ELVN) stock.

The initial trade took place in 2023Q1. And since then COMMODORE CAPITAL LP has made 7 purchases of ELVN, at an average price of $19.77, for a total of 4.67 Mil shares. Based on historical transaction data and ELVN's current price of $22.02, COMMODORE CAPITAL LP's estimated gain on his ELVN holdings is $10.52 Mil, reflecting a 11.38% gain to date.

COMMODORE CAPITAL LP ELVN ($22.02) Holding Chart

COMMODORE CAPITAL LP ELVN ($22.02) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1